Position in GILD
as of Jun 30, 2026
· filed Aug 21, 2026
Position Value
$4,985,123
+$832,455 QoQ
Shares Held
39,458
+32.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.46%
of 13F equity value
Holder Rank
#581
of 2,266 holders
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WEST MICHIGAN ADVISORS, LLC holds $25,509,466 across 8 Drug Manufacturers - General names. GILD ranks #2 (19.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
44,438 | $5,710,283 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
39,458 | $4,985,123 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
82,237 | $4,738,495 | |
| 4 | ABBV |
AbbVie Inc.
|
16,983 | $4,273,602 | |
| 5 | JNJ |
Johnson & Johnson
|
10,207 | $2,592,271 | |
| 6 | LLY |
ELI LILLY & Co
|
2,160 | $2,590,769 | |
| 7 | AZN |
Astrazeneca PLC
|
1,636 | $310,218 | |
| 8 | PFE |
Pfizer Inc
|
12,820 | $308,705 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,985,123 | 39,458 | Shares | Sole | 2026-08-21 | |
| 2026-03-31 | $4,152,668 | 29,796 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $3,277,771 | 26,705 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $2,501,052 | 22,532 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $473,193 | 4,268 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $639,469 | 5,707 | Shares | Sole | 2025-05-09 | |
| 2021-12-31 | $388,608 | 5,352 | Shares | Sole | 2022-02-15 | |
| No filing history on record for this holder in this stock. | ||||||